Trade Summary

4 days ago, Carroll Jill, serving as Dir at Avalyn Pharma Inc. (AVLN), purchased 277,778 shares at $18.00 per share, for a total transaction value of $5,000,004.00. Following this transaction, Carroll Jill now holds 2,186,562 shares of AVLN.

This purchase represents a 15.00% increase in Carroll Jill's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Friday, May 1, 2026 and publicly disclosed via SEC Form 4 filing on Friday, May 1, 2026, meaning the disclosure happened on the same day as the trade.

Avalyn Pharma Inc. operates in the NONE sector, specifically within the NONE industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.